FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease - FDA.gov
- FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease FDA.gov
- Gene editing could be a game changer for patients with sickle cell disease CBS Mornings
- F.D.A. Approves 2 Sickle Cell Treatments, One Using CRISPR Gene Editing The New York Times
- A Sickle Cell Breakthrough Is Here. Now the Hard Part. Bloomberg
- The Download: inside the first CRISPR treatment, and smarter robots MIT Technology Review